Skip to main content
    C

    Calidi Biotherapeutics Inc. (CLDI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.60
    -0.02 (-2.93%)

    Market Cap: $2.29M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Calidi Biotherapeutics Inc. (CLDI) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Calidi Biotherapeutics reported EPS of -$1.47. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    33%(3/9)
    Avg Surprise
    -67.11%

    Next Report

    CLDI's next report is not on the earnings calendar yet.

    Earnings History

    Of the 9 quarters below that had an estimate, CLDI beat 3 and missed 6. The widest gap in the table came in the quarter ended Sep 30, 2023, when EPS landed 210.93% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$1.47N/AN/AN/AN/AN/AN/AN/ANov 13, 2026
    Jun 30, 2026-$2.94N/AN/AN/AN/AN/AN/AN/AAug 13, 2026
    Sep 30, 2025-$2.21-$1.68-$1.68 - -$1.68-31.55%MissN/A10 up, 1 downNov 13, 2025
    Jun 30, 2025-$1.99-$1.32-$1.32 - -$1.32-50.76%MissN/A10 up, 0 downAug 8, 2025
    Mar 31, 2025-$2.25-$1.80-$1.80 - -$1.80-25.00%MissN/A10 up, 0 downApr 4, 2025
    Dec 31, 2024-$0.27-$0.09N/A-200.00%MissN/A20 up, 0 downMar 31, 2025
    Sep 30, 2024-$7.80-$10.26-$13.09 - -$7.44+23.98%BeatN/A20 up, 0 downNov 12, 2024
    Jun 30, 2024-$16.80-$17.40-$19.00 - -$9.60+3.45%BeatN/A20 up, 0 downAug 13, 2024
    Mar 31, 2024-$23.71-$32.40N/A+26.82%BeatN/A20 up, 0 downMay 14, 2024
    Dec 31, 2023-$0.48-$0.20-$0.21 - -$0.20-140.00%MissN/A20 up, 0 downMar 19, 2024
    Sep 30, 2023-$63.43-$20.40N/A-210.93%Miss-317250.0%N/AN/ANov 14, 2023
    Jun 30, 2023-$0.43N/AN/AN/AN/A-408.6%N/AN/AAug 30, 2023
    Mar 31, 2023-$27.02N/AN/AN/AN/A-54148.2%N/AN/AJun 28, 2023
    Dec 31, 2022-$0.26N/AN/AN/AN/A-273.3%N/AN/AMar 30, 2023
    Sep 30, 2022$0.02N/AN/AN/AN/AN/AN/AN/ANov 14, 2022
    Jun 30, 2022$0.14N/AN/AN/AN/AN/AN/AN/ASep 28, 2022
    Mar 31, 2022$0.05N/AN/AN/AN/AN/AN/AN/AJun 28, 2022
    Dec 31, 2021$0.15N/AN/AN/AN/AN/AN/AN/AMar 29, 2022
    Sep 30, 2021-$0.03N/AN/AN/AN/AN/AN/AN/ADec 29, 2021
    Jun 30, 2021Not reportedN/AN/AN/ANot reportedN/AN/AN/ASep 28, 2021
    Last 20 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2024 was -$48.58, after -$91.37 the year before. It was $0.12 for the year ended Dec 31, 2021, the oldest of the 4 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2024-$48.58N/A
    Dec 31, 2023-$91.37N/A
    Dec 31, 2022-$0.05-141.7%
    Dec 31, 2021$0.12N/A

    Frequently Asked Questions About CLDI

    How often does CLDI beat earnings estimates?

    Calidi Biotherapeutics beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -49.13%.